Home » Topics » BioWorld Science

BioWorld Science
RSS

NeoTherapeutics adds site to Neotrofin SCI study

July 3, 2001

Novavax seeks approval of Estrasorb in U.S.; expands license agreement with King

July 3, 2001

New AGE production inhibitor with promise in diabetic nephropathy

July 3, 2001

CollaGenex launches tablet formulation of Periostat

July 3, 2001

Small-molecule LFA-1 antagonist enters phase I studies

July 3, 2001

Org-25935 dose-dependently increases striatal glycine levels in rats

July 3, 2001

ADA news: glycemic control and lipid profiles improve on INS-1 + sulfonylurea in type 2 diabetes

July 3, 2001

Roche licenses levovirin from ICN

July 3, 2001

SafeScience to create joint venture with Elan for phase II anticancer agent

July 3, 2001

Exclusivity period for human gene therapeutic consortium expires

July 3, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...